These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24789847)

  • 1. The natural history of cervical cancer in chinese women: results from an 11-year follow-up study in china using a multistate model.
    Zhang SK; Kang LN; Chang IJ; Zhao FH; Hu SY; Chen W; Shi JF; Zhang X; Pan QJ; Li SM; Qiao YL
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1298-305. PubMed ID: 24789847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Three-year follow-up results of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an alternative screening method for cervical cancer in rural areas].
    Zhang YZ; Ma JF; Zhao FH; Xiang XE; Ma ZH; Shi YT; Hu SY; Qiao YL
    Chin J Cancer; 2010 Jan; 29(1):4-8. PubMed ID: 20038302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
    Syrjänen K; Shabalova I; Sarian L; Naud P; Longatto-Filho A; Derchain S; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Serpa Hammes L; Podistov J; Costa S; Syrjänen S; ;
    Eur J Gynaecol Oncol; 2012; 33(1):5-14. PubMed ID: 22439398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prospective study on the prognosis of biopsy-confirmed cervical intraepithelial neoplasia grade 1 and the relationship with high-risk human papillomavirus].
    Hu S; Zhao F; Ma J; Wang X; Han J; Li A; Chen F; Zhang X; Pan Q; Qiao Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 May; 48(5):361-5. PubMed ID: 24985373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China.
    Hu SY; Rezhake R; Chen F; Zhang X; Pan QJ; Ma JF; Qiao YL; Zhao FH
    Gynecol Oncol; 2020 Mar; 156(3):616-623. PubMed ID: 31937451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.
    Heselmeyer-Haddad K; Sommerfeld K; White NM; Chaudhri N; Morrison LE; Palanisamy N; Wang ZY; Auer G; Steinberg W; Ried T
    Am J Pathol; 2005 Apr; 166(4):1229-38. PubMed ID: 15793301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
    Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
    Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.
    Wang SM; Colombara D; Shi JF; Zhao FH; Li J; Chen F; Chen W; Li SM; Zhang X; Pan QJ; Belinson JL; Smith JS; Qiao YL
    Int J Gynecol Cancer; 2013 May; 23(4):716-23. PubMed ID: 23455757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma expression of miRNA-21, - 214, -34a, and -200a in patients with persistent HPV infection and cervical lesions.
    Wang H; Zhang D; Chen Q; Hong Y
    BMC Cancer; 2019 Oct; 19(1):986. PubMed ID: 31646977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meta-analysis of annual probability of outcome for different cervical disease states].
    You TT; Xia CF; Chen M; Qiao YL; Zhao FH
    Zhonghua Yi Xue Za Zhi; 2021 Jun; 101():1899-1907. PubMed ID: 34192842
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential DNA copy number aberrations in the progression of cervical lesions to invasive cervical carcinoma.
    Oh EK; Kim YW; Kim IW; Liu HB; Lee KH; Chun HJ; Park DC; Oh EJ; Lee AW; Bae SM; Ahn WS
    Int J Oncol; 2012 Dec; 41(6):2038-46. PubMed ID: 23023522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study.
    Skorstengaard M; Lynge E; Suhr J; Napolitano G
    BJOG; 2020 May; 127(6):729-736. PubMed ID: 31880054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-Colposcopy Management and Progression Predictors of Biopsy-Proven CIN1 in Women Under 25 Years.
    Loopik DL; Bekkers RLM; Massuger LFAG; Melchers WJG; Siebers AG; Bentley JR
    J Obstet Gynaecol Can; 2019 Mar; 41(3):292-299. PubMed ID: 30786980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.
    Wang SS; Zuna RE; Wentzensen N; Dunn ST; Sherman ME; Gold MA; Schiffman M; Wacholder S; Allen RA; Block I; Downing K; Jeronimo J; Carreon JD; Safaeian M; Brown D; Walker JL
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):113-20. PubMed ID: 19124488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study.
    Pacchiarotti A; Ferrari F; Bellardini P; Chini F; Collina G; Dalla Palma P; Ghiringhello B; Maccallini V; Musolino F; Negri G; Pisa R; Sabatucci I; Giorgi Rossi P
    Int J Cancer; 2014 Feb; 134(4):897-904. PubMed ID: 23913416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3.
    Syrjänen K; Shabalova I; Naud P; Derchain S; Sarian L; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Hammes LS; Costa S; Podistov J; Syrjänen S; ; ;
    Int J STD AIDS; 2011 May; 22(5):263-72. PubMed ID: 21571974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
    Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
    Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study.
    Matsumoto K; Maeda H; Oki A; Takatsuka N; Yasugi T; Furuta R; Hirata R; Mitsuhashi A; Fujii T; Hirai Y; Iwasaka T; Yaegashi N; Watanabe Y; Nagai Y; Kitagawa T; Yoshikawa H;
    Int J Gynecol Cancer; 2012 Mar; 22(3):471-8. PubMed ID: 22391763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.